Kymera Therapeutics
KYMR
KYMR
97 hedge funds and large institutions have $887M invested in Kymera Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 6 closing their positions.
Holders
97
Holders Change
+22
Holders Change %
+29.33%
% of All Funds
1.71%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
28
Reduced
25
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$67.3M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$36.4M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$36.3M |
| 4 |
4
Janus Henderson Group
London,
United Kingdom
|
$15.5M |
| 5 |
5
Morgan Stanley
New York
|
$13.6M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FCM
101
Firestone Capital Management
Coral Gables,
Florida
| – | – | -100 | Closed |
|
102
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
CFGS
103
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
CS
104
Candriam SCA
Strassen, Luxembourg,
Luxembourg
| $0 | 7 | +7 | New |
|
105
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $0 | 7 | +7 | New |
|